Lb Pharmaceuticals (LBRX) Tax Rate (2024 - 2025)

Lb Pharmaceuticals' (LBRX) quarterly Tax Rate came in at 0.01% in Q4 2025, up 1.0% year-on-year from 0.01% in Q4 2024, and up 55.8% quarter-over-quarter from 0.02% in Q4 2024.

Lb Pharmaceuticals (LBRX) Tax Rate (2024 - 2025) Analysis & Trends

Lb Pharmaceuticals' Tax Rate history runs 2 years deep, the most recent figure standing at 0.01% for Q4 2025.

  • On a quarterly basis, Tax Rate rose 1.0% year-over-year to 0.01% in Q4 2025; TTM through Mar 2026 was 0.0%, a N/A change from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
  • Tax Rate rose to 0.01% in Q4 2025 per LBRX's latest filing, from 0.02% in the prior quarter.
  • Across five years, Tax Rate topped out at 0.01% in Q4 2025 and bottomed at 0.02% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -0.34%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.29%
4 NuCana 279.75 Bn 279.75 Bn - -5.41%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 17.68%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 12.51%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 33.09%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Lb Pharmaceuticals 977.73 Mn 977.73 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.01%
Dec 31, 2025 -0.01%
Dec 31, 2025 -0.01%
Dec 31, 2024 -0.02%
Dec 31, 2024 -0.02%
Dec 31, 2024 -0.02%